Iterative Scopes Inc is a software company that specializes in artificial intelligence (AI) and machine learning (ML) for data-driven businesses. The company's product, DVC, is an open-source data version control system that allows data scientists and engineers to manage their ML models, data, and code more efficiently. The company aims to democratize access to AI and ML by providing an accessible and collaborative platform for businesses of all sizes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/19/2022 | Series B | $150MM | $xx.xx | $704.24MM | Breyer Capital, Clearlake Capital, Eli Lilly, Insight Partners, Johnson & Johnson Innovation, Obvious Ventures | |
Price per Share
$xx.xx
Shares Outstanding
9,014,048
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, Clearlake Capital, Eli Lilly, Insight Partners, Johnson & Johnson Innovation, Obvious Ventures
|
||||||
08/03/2021 | Series A-2 | $4.24MM | $xx.xx | $133.45MM | Breyer Capital, Eli Lilly, Johnson & Johnson, Lee Shapiro, Nat Turner, Obvious Ventures, Seae Ventures, Zach Weinberg | |
Price per Share
$xx.xx
Shares Outstanding
1,051,225
Liquidation Pref Order
1
Liquidation Pref As Multiplier
0.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, Eli Lilly, Johnson & Johnson, Lee Shapiro, Nat Turner, Obvious Ventures, Seae Ventures, Zach Weinberg
|
||||||
08/03/2021 | Series A-1 | $30MM | $xx.xx | $133.45MM | Breyer Capital, Eli Lilly, Johnson & Johnson, Lee Shapiro, Nat Turner, Obvious Ventures, Seae Ventures, Zach Weinberg | |
Price per Share
$xx.xx
Shares Outstanding
7,435,936
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, Eli Lilly, Johnson & Johnson, Lee Shapiro, Nat Turner, Obvious Ventures, Seae Ventures, Zach Weinberg
|
||||||
01/15/2020 | Pre Series A | $13.25MM | $xx.xx | $29.43MM | Freddie Kerrest, P5gv, Tau Ventures, Wavemaker Partners | |
Price per Share
$xx.xx
Shares Outstanding
9,705,116
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Freddie Kerrest, P5gv, Tau Ventures, Wavemaker Partners
|